Loading clinical trials...

Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT04681300

Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing

Prurigo nodularis (PN) is a skin condition characterized by symmetrically distributed widespread, pruritic nodules that occurs in patients with chronic pruritus. There are 2 subtypes of PN depending o...

Lead sponsor: Assistance Publique - Hôpitaux de Paris•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Jean-David BOUAZIZ

CONTACT

01 42 49 43 19 [email protected]

Matthieu RESCHE-RIGON

CONTACT

+33142499742 [email protected]

Related studies

RECRUITINGPhase 2

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

NCT07223697 · Atopic Dermatitis

RECRUITINGPhase 2

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT07298395 · Atopic Dermatitis (AD)

RECRUITINGPhase 2

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

NCT07217015 · Atopic Dermatitis

RECRUITINGPhase 4

Dupilumab De-escalation in Pediatric Atopic Dermatitis

NCT06116526 · Atopic Dermatitis

RECRUITINGPhase 4

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

NCT07006792 · Atopic Dermatitis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 9, 2021Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment20

Start dateFeb 2021

Last updatedFeb 9, 2021

Condition

Prurigo Nodularis Atopic Dermatitis

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 9, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing

What this study is about

Save this trial guide to your notes

Contacts

Sponsors

Related studies

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

Dupilumab De-escalation in Pediatric Atopic Dermatitis

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

Trial snapshot

Condition

For caregivers